Medical know-how firm Masimo has been going through off with Apple in court docket since 2020, and whereas Masimo has scored some wins, it has been an costly endeavor.
In its quarterly earnings stories, Masimo outlines how a lot it has spent on litigation. The best way Masimo’s spending is reported has modified during the last 5 years, however taking a look at earnings stories give a normal concept of the fee to sue Apple and the way these prices can balloon.
Masimo’s ITC case towards Apple started in 2021, and it in the end led to an Apple Watch import ban. Apple was compelled to take away blood oxygen monitoring from Apple Watches offered within the U.S. in December 2023. Masimo spent $5.5 million on litigation bills in 2021, adopted by $28.7 million in 2022. The corporate spent over $40 million in 2023, and $70 million in 2024.
Within the first quarter of 2025, Masimo spent $19.7 million, and in its second quarter earnings outcomes shared this week, Masimo mentioned it spent $24 million on litigation. Masimo may very well be on monitor to spend extra in 2025 than it did in 2024, based mostly on its authorized prices within the first and second quarters. Proper now, Masimo is embroiled within the appeals course of with Apple, as Apple launched an enchantment in late 2023. Most lately, Apple argued its appeals case to a three-judge panel, although no choice has been made as of but.
These litigation figures embody all of Masimo’s authorized spending, and never simply what the Apple-related prices. The Apple lawsuit is Masimo’s most important authorized battle, nonetheless, and it seemingly accounts for many of Masimo’s complete spending.
In December 2023, then Masimo CEO Joe Kiani told The Wall Street Journal that the authorized battle towards Apple had value Masimo round $100 million. Wanting on the authorized prices Masimo reported in 2024 and 2025, the full may very well be approaching $200 million.